NEW YORK (GenomeWeb) — HiberGene Diagnostics said today that it has secured a non-exclusive license to use Eiken Chemical's loop-mediated isothermal amplification (LAMP) technology.

Specifically, Dublin-based HiberGene gains the rights to develop, manufacture, and market diagnostic products for human infectious diseases using LAMP in exchange for an undisclosed license fee and royalty payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.